Patents Assigned to NORTH TEXAS MEDICAL ASSOCIATES
  • Patent number: 8883855
    Abstract: Compositions and therapeutic uses of HEPES and derivatives in the treatment of pain associated with cancers and side-effects including post-chemotherapy cognitive impairment are disclosed herein. HEPES is also used to treat neurodegenerative and neurological diseases, demyelinization injuries, and side-effects and withdrawal symptoms associated with benzodiazepines, anti-depressants, and other neurological agents.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: November 11, 2014
    Assignee: North Texas Medical Associates
    Inventor: Ivan E. Danhof
  • Publication number: 20140093593
    Abstract: The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 MPS, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 MPS, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 MPS and water.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 3, 2014
    Applicant: North Texas Medical Associates
    Inventor: Ivan E. Danhof
  • Publication number: 20140057867
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Application
    Filed: November 4, 2013
    Publication date: February 27, 2014
    Applicant: North Texas Medical Associates
    Inventor: Ivan E. Danhof
  • Patent number: 8604187
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: December 10, 2013
    Assignee: North Texas Medical Associates
    Inventor: Ivan E. Danhof
  • Publication number: 20120022018
    Abstract: A pharmaceutical composition comprising a combination of formulations derived from Aloe vera for the treatment of Acquired Immune Deficiency Syndrome (AIDS) or HIV infection is described herein. The composition comprises: (i) an injectable sterile polymannan extract, (ii) Raidox (aloe anthraquinones and their diacetyl derivatives), and (iii) a freeze dried aloe vera powder, aloe vera juice, aloe gel or a combination. In addition one or more nutritional supplements comprising fatty acids, proteins, minerals and metals, vitamins, salts, amino acids, and other pharmaceutically acceptable excipients may also be include to counteract the chronic diarrhea, digestive upsets, and weight loss seen in some patients before and during the treatment course. A method for treating the AIDS or HIV infection using the composition of the present invention is also disclosed.
    Type: Application
    Filed: July 20, 2011
    Publication date: January 26, 2012
    Applicant: NORTH TEXAS MEDICAL ASSOCIATES
    Inventor: Ivan E. Danhof
  • Publication number: 20110300227
    Abstract: Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well as correcting defective biochemical pathways and systems in the body.
    Type: Application
    Filed: May 20, 2011
    Publication date: December 8, 2011
    Applicant: NORTH TEXAS MEDICAL ASSOCIATES
    Inventor: Ivan E. Danhof
  • Publication number: 20110172181
    Abstract: The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
    Type: Application
    Filed: January 6, 2011
    Publication date: July 14, 2011
    Applicant: North Texas Medical Associates
    Inventor: Ivan E. Danhof
  • Publication number: 20110071157
    Abstract: Compositions and therapeutic uses of HEPES and derivatives in the treatment of pain associated with cancers and side-effects including post-chemotherapy cognitive impairment are disclosed herein. HEPES is also used to treat neurodegenerative and neurological diseases, demyelinization injuries, and side-effects and withdrawal symptoms associated with benzodiazepines, anti-depressants, and other neurological agents.
    Type: Application
    Filed: September 17, 2010
    Publication date: March 24, 2011
    Applicant: NORTH TEXAS MEDICAL ASSOCIATES
    Inventor: Ivan E. Danhof